' '
Deutsch | English    

Research Database PMU-SQQUID


chosen keywordTolerability

Nivolumab for locally advanced and metastatic cutaneous squamous cell carcinoma (NIVOSQUACS study) - phase II data covering impact of concomitant hematological malignancies.
Lang, R; Welponer, T; Richtig, E; Wolf, I; Hoeller, C; Hafner, C; Nguyen, VA; Kofler, J; Barta, M; Koelblinger, P; Hitzl, W; Emberger, M; Laimer, M;
J Eur Acad Dermatol Venereol. 2023;
Full papers/articles (Journal)
Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data
Hauer, L; Sellner, J
DRUG DES DEV THER. 2022; 16: 3915-3927.
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.
Kuemmel, S; Campone, M; Loirat, D; Lopez, RL; Beck, JT; De Laurentiis, M; Im, SA; Kim, SB; Kwong, A; Steger, GG; Adelantado, EZ; Duhoux, FP; Greil, R; Kuter, I; Lu, YS; Tibau, A; Özgüroğlu, M; Scholz, CW; Singer, CF; Vega, E; Wimberger, P; Zamagni, C; Couillebault, XM; Fan, L; Guerreiro, N; Mataraza, J; Sand-Dejmek, J; Chan, A;
Clin Cancer Res. 2022; 28(1): 106-115.
Full papers/articles (Journal)
Atogepant for the Prevention of Episodic Migraine in Adults: A Systematic Review and Meta-Analysis of Efficacy and Safety.
Lattanzi, S; Trinka, E; Altamura, C; Del Giovane, C; Silvestrini, M; Brigo, F; Vernieri, F
NEUROL THER. 2022; 11(3): 1235-1252.
A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery.
Lorenzl, S; Gottwald, F; Nistler, A; Brehm, L; Grötsch, R; Haber, G; Bremm, C; Weck, C; Trummer, C; Brand, W;
Med Cannabis Cannabinoids. 2022; 5(1):-19
Full papers/articles (Journal)
Diagnosis and treatment of arterial hypertension 2021.
Ott, C; Schmieder, RE;
Kidney Int. 2022; 101(1): 3-46.
A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14.
Rentsch, CA; Thalmann, GN; Lucca, I; Kwiatkowski, M; Wirth, GJ; Strebel, RT; Engeler, D; Pedrazzini, A; Hüttenbrink, C; Schultze-Seemann, W; Torpai, R; Bubendorf, L; Wicki, A; Roth, B; Bosshard, P; Püschel, H; Boll, DT; Hefermehl, L; Roghmann, F; Gierth, M; Ribi, K; Schäfer, S; Hayoz, S;
Eur Urol Oncol. 2022; 5(2): 195-202.
Full papers/articles (Journal)
[Wound therapy with cold atmospheric plasma in severe recessive dystrophic epidermolysis bullosa : A pilot study].
Thiem, A; Has, C; Diem, A; Klausegger, A; Hamm, H; Emmert, S;
Hautarzt. 2022; 73(5): 384-390.
Case Reports
A Systematic Review and Meta-analysis of Chemoablation for Non-muscle-invasive Bladder Cancer.
Yanagisawa, T; Quhal, F; Kawada, T; Mostafaei, H; Motlagh, RS; Laukhtina, E; Rajwa, P; Deimling, MV; Bianchi, A; Pallauf, M; Majdoub, M; Pradere, B; Moschini, M; Karakiewicz, PI; Teoh, JY; Miki, J; Kimura, T; Shariat, SF;
Eur Urol Focus. 2022;
Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa.
Kiritsi, D; Dieter, K; Niebergall-Roth, E; Fluhr, S; Daniele, C; Esterlechner, J; Sadeghi, S; Ballikaya, S; Erdinger, L; Schauer, F; Gewert, S; Laimer, M; Bauer, JW; Hovnanian, A; Zambruno, G; El Hachem, M; Bourrat, E; Papanikolaou, M; Petrof, G; Kitzmüller, S; Ebens, CL; Frank, MH; Frank, NY; Ganss, C; Martinez, AE; McGrath, JA; Tolar, J; Kluth, MA;
JCI Insight. 2021; 6(22):
Full papers/articles (Journal)
Pharmacokinetics and safety of capmatinib with food in patients with MET-dysregulated advanced solid tumors.
Moreno, V; Greil, R; Yachnin, J; Majem, M; Wermke, M; Arkenau, HT; Basque, JR; Nidamarthy, PK; Kapoor, S; Cui, XM; Giovannini, M
CLIN THER. 2021; 43(6): 1092-1111.
Full papers/articles (Journal)
Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany.
Strzelczyk, A; Pringsheim, M; Mayer, T; Polster, T; Klotz, KA; Muhle, H; Alber, M; Trollmann, R; Spors, H; Kluger, G; Kurlemann, G; Schubert-Bast, S
Epilepsia. 2021; 62(10):2518-2527
Full papers/articles (Journal)
PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice
Villanueva, V; D'Souza, W; Goji, H; Kim, DW; Liguori, C; McMurray, R; Najm, I; Santamarina, E; Steinhoff, BJ; Vlasov, P; Wu, T; Trinka, E
J NEUROL. 2021;
Full papers/articles (Journal)
Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients" Perspectives.
Willems, LM; Rosenow, F; Schubert-Bast, S; Kurlemann, G; Zollner, JP; Bast, T; Bertsche, A; Bettendorf, U; Ebrahimi-Fakhari, D; Grau, J; Hahn, A; Hartmann, H; Hertzberg, C; Hornemann, F; Immisch, I; Jacobs, J; Klein, KM; Klotz, KA; Kluger, G; Knake, S; Knuf, M; Marquard, K; Mayer, T; Meyer, S; Muhle, H; Muller-Schluter, K; von Podewils, F; Ruf, S; Sauter, M; Schafer, H; Schlump, JU; Syrbe, S; Thiels, C; Trollmann, R; Wiemer-Kruel, A; Wilken, B; Zukunft, B; Strzelczyk, A
CNS DRUGS. 2021; 35(10): 1107-1122.
Full papers/articles (Journal)
Single-use IgE-selective immunoadsorber column for the treatment of severe atopic dermatitis.
Meyersburg, D; Laimer, M; Kugler, A; Mühlthaler, E; Lindlbauer, N; Hitzl, W; Rohde, E; Bauer, JW; Grabmer, C;
J Clin Apher. 2020; 35(1): 50-58.
Full papers/articles (Journal)
Translational perspectives to treat Epidermolysis bullosa-Where do we stand?
Prodinger, C; Bauer, JW; Laimer, M;
Exp Dermatol. 2020; 29(11):1112-1122
Full papers/articles (Journal)
Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria.
Rendl, G; Sipos, B; Becherer, A; Sorko, S; Trummer, C; Raderer, M; Hitzl, W; Ardelt, M; Gallowitsch, HJ; Pirich, C;
Int J Endocrinol. 2020; 2020: 8834148
Full papers/articles (Journal)
Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.
Sävendahl, L; Battelino, T; Brod, M; Højby Rasmussen, M; Horikawa, R; Juul, RV; Saenger, P;
J Clin Endocrinol Metab. 2020; 105(4):
Full papers/articles (Journal)
A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity.
Weghuber, D; Forslund, A; Ahlström, H; Alderborn, A; Bergström, K; Brunner, S; Cadamuro, J; Ciba, I; Dahlbom, M; Heu, V; Hofmann, J; Kristinsson, H; Kullberg, J; Ladinger, A; Lagler, FB; Lidström, M; Manell, H; Meirik, M; Mörwald, K; Roomp, K; Schneider, R; Vilén, H; Widhalm, K; Zsoldos, F; Bergsten, P;
Pediatr Obes. 2020; 15(7): e12624
Full papers/articles (Journal)
Antiepileptic drug monotherapy for epilepsy in the elderly: A systematic review and network meta-analysis.
Lattanzi, S; Trinka, E; Del Giovane, C; Nardone, R; Silvestrini, M; Brigo, F;
Epilepsia. 2019; 60(11):-2254.
Full papers/articles (Journal)
Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis.
Lattanzi, S; Zaccara, G; Giovannelli, F; Grillo, E; Nardone, R; Silvestrini, M; Trinka, E; Brigo, F;
Acta Neurol Scand. 2019; 139(1): 33-41.
Perampanel: Does it have broad-spectrum potential?
Potschka, H; Trinka, E;
Epilepsia. 2019; 60 Suppl 1:22-36
Perampanel in the treatment of status epilepticus: A systematic review of the literature.
Brigo, F; Lattanzi, S; Rohracher, A; Russo, E; Meletti, S; Grillo, E; Trinka, E
EPILEPSY BEHAV. 2018; 86: 179-186.
Randomized controlled trials of antiepileptic drugs for the treatment of post-stroke seizures: A systematic review with network meta-analysis.
Brigo, F; Lattanzi, S; Zelano, J; Bragazzi, NL; Belcastro, V; Nardone, R; Trinka, E;
Seizure. 2018; 61: 57-62.
Decolonization potential of 0.02% polyhexanide irrigation solution in urethral catheters under practice-like in vitro conditions.
Brill, FHH; Gabriel, H; Brill, H; Klock, JH; Steinmann, J; Arndt, A;
BMC Urol. 2018; 18(1): 49
Full papers/articles (Journal)
Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice - results from the ElderTac study.
Brueckl, WM; Achenbach, HJ; Ficker, JH; Schuette, W;
BMC Cancer. 2018; 18(1): 333
Full papers/articles (Journal)
A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.
Burgstaller, S; Stauder, R; Kuehr, T; Lang, A; Machherndl-Spandl, S; Mayrbaeurl, B; Noesslinger, T; Petzer, A; Valent, P; Greil, R; Thaler, J;
Leuk Lymphoma. 2018; 59(5):1121-1126
Full papers/articles (Journal)
A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc
Greil, R; Greil-Ressler, S; Weiss, L; Schönlieb, C; Magnes, T; Radl, B; Bolger, GT; Vcelar, B; Sordillo, PP;
Cancer Chemother Pharmacol. 2018; 82(4): 695-706.
Full papers/articles (Journal)
Development of encorafenib for BRAF-mutated advanced melanoma.
Koelblinger, P; Thuerigen, O; Dummer, R;
Curr Opin Oncol. 2018; 30(2): 125-133.
Full papers/articles (Journal)
Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials.
Krauss, G; Biton, V; Harvey, JH; Elger, C; Trinka, E; Soares da Silva, P; Gama, H; Cheng, H; Grinnell, T; Blum, D;
Epilepsy Res. 2018; 139:1-8
Full papers/articles (Journal)
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Fuchs, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Bartsch, R; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R;
BMC Cancer. 2018; 18(1): 1074
Full papers/articles (Journal)
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
Biton, V; Rogin, JB; Krauss, G; Abou-Khalil, B; Rocha, JF; Moreira, J; Gama, H; Trinka, E; Elger, CE; Cheng, HL; Grinnell, T; Blum, D
Epilepsy Behav. 2017; 72:127-134
Full papers/articles (Journal)
Advanced non-small cell lung cancer (NSCLC) with activating EGFR mutations: first-line treatment with afatinib and other EGFR TKIs.
Brückl, W; Tufman, A; Huber, RM;
Expert Rev Anticancer Ther. 2017; 17(2): 143-155.
Full papers/articles (Journal)
Re: Auch mit DOAK bleibt es kompliziert
Engels, T; Hoppenrath, HG; Gosch, M; Heppner, HJ;
MMW Fortschr Med. 2017; 159(6): 26
Author reply
The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.
Fountoulakis, KN; Yatham, L; Grunze, H; Vieta, E; Young, A; Blier, P; Kasper, S; Moeller, HJ
Int J Neuropsychopharmacol. 2017; 20(2):121-179
Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational study.
Schmid, E; Kuchukhidze, G; Kirschner, M; Leitinger, M; Höfler, J; Rohracher, A; Kalss, G; Wendling, AS; Steinhoff, BJ; Trinka, E;
Acta Neurol Scand. 2017; 135(4): 449-453.
Full papers/articles (Journal)
Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.
Shorvon, SD; Trinka, E; Steinhoff, BJ; Holtkamp, M; Villanueva, V; Peltola, J; Ben-Menachem, E;
J Neurol. 2017; 264(3): 42-431.
Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with meta-analysis of randomized controlled trials.
Brigo, F; Bragazzi, NL; Bacigaluppi, S; Nardone, R; Trinka, E;
Epilepsy Behav. 2016; 64(Pt A): 29-36.
Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
Brigo, F; Bragazzi, NL; Nardone, R; Trinka, E;
Seizure. 2016; 42:29-37
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Levin, J; Maass, S; Schuberth, M; Respondek, G; Paul, F; Mansmann, U; Oertel, WH; Lorenzl, S; Krismer, F; Seppi, K; Poewe, W; Wenning, G; Giese, A; Botzel, K; Hoglinger, G
J NEURAL TRANSM. 2016; 123(4): 439-445.
Full papers/articles (Journal)
PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy.
Nuebling, G; Hensler, M; Paul, S; Zwergal, A; Crispin, A; Lorenzl, S;
J Neurol. 2016; 263(8): 1565-1574.
Full papers/articles (Journal)
Perampanel for the treatment of primary generalized tonic-clonic seizures in idiopathic generalized epilepsy.
Rohracher, A; Brigo, F; Höfler, J; Kalss, G; Neuray, C; Dobesberger, J; Kuchukhidze, G; Leitinger, M; Trinka, E;
Expert Opin Pharmacother. 2016; 17(10):1403-1411
Full papers/articles (Journal)
Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data
Rohracher, A; Kalss, G; Leitinger, M; Granbichler, C; Deak, I; Dobesberger, J; Kuchukhidze, G; Thomschewski, A; Hofler, J; Trinka, E
THER ADV NEUROL DISO. 2016; 9(6): 445-453.
Full papers/articles (Journal)
Pharmacologic treatment of status epilepticus.
Trinka, E; Höfler, J; Leitinger, M; Rohracher, A; Kalss, G; Brigo, F;
Expert Opin Pharmacother. 2016; 17(4):51-34
Full papers/articles (Journal)
Perampanel for focal epilepsy: insights from early clinical experience.
Trinka, E; Steinhoff, BJ; Nikanorova, M; Brodie, MJ;
Acta Neurol Scand. 2016; 133(3): 160-172.
Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain.
Ueberall, MA; Lorenzl, S; Lux, EA; Voltz, R; Perelman, M;
J Pain Res. 2016; 9: 571-585.
Full papers/articles (Journal)
Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies: first experiences.
Biro, A; Stephani, U; Tarallo, T; Bast, T; Schlachter, K; Fleger, M; Kurlemann, G; Fiedler, B; Leiz, S; Nikanorova, M; Wolff, M; Muller, A; Selch, C; Staudt, M; Kluger, G
NEUROPEDIATRICS. 2015; 46(2): 110-115.
Full papers/articles (Journal)
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.
Brinton, EA; Kher, U; Shah, S; Cannon, CP; Davidson, M; Gotto, AM; Ashraf, TB; McCrary Sisk, C; Dansky, H; Mitchel, Y; Barter, P;
J Clin Lipidol. 2015; 9(1): 65-71.
Full papers/articles (Journal)
Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I.
Grunze, H; Kotlik, E; Costa, R; Nunes, T; Falcão, A; Almeida, L; Soares-da-Silva, P;
J Affect Disord. 2015; 174:70-82
Full papers/articles (Journal)
Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial.
Mohr, P; Hauschild, A; Trefzer, U; Enk, A; Tilgen, W; Loquai, C; Gogas, H; Haalck, T; Koller, J; Dummer, R; Gutzmer, R; Brockmeyer, N; Holzle, E; Sunderkotter, C; Mauch, C; Stein, A; Schneider, LA; Podda, M; Goppner, D; Schadendorf, D; Weichenthal, M
J Clin Oncol. 2015; 33(34):4077-4084
Full papers/articles (Journal)
Safety and tolerability of anticonvulsant medication in bipolar disorder.
Pichler, EM; Hattwich, G; Grunze, H; Muehlbacher, M;
Expert Opin Drug Saf. 2015; 14(11):1703-1724
Full papers/articles (Journal)
Nothing like Christmas--suicides during Christmas and other holidays in Austria.
Plöderl, M; Fartacek, C; Kunrath, S; Pichler, EM; Fartacek, R; Datz, C; Niederseer, D;
Eur J Public Health. 2015; 25(3): 410-413.
Full papers/articles (Journal)
Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
Tomic, V; Tomic, J; Klaic, DZ; Kasum, M; Kuna, K;
Eur J Obstet Gynecol Reprod Biol. 2015; 186: 49-53.
Full papers/articles (Journal)
Collagenase clostridium histolyticum in patients with Dupuytren"s contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes.
Warwick, D; Arner, M; Pajardi, G; Reichert, B; Szabo, Z; Masmejean, EH; Fores, J; Chapman, DS; Gerber, RA; Huard, F; Seghouani, A; Szczypa, PP;
J Hand Surg Eur Vol. 2015; 40(2):124-132
Full papers/articles (Journal)
A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy.
Werhahn, KJ; Trinka, E; Dobesberger, J; Unterberger, I; Baum, P; Deckert-Schmitz, M; Kniess, T; Schmitz, B; Bernedo, V; Ruckes, C; Ehrlich, A; Kramer, G
EPILEPSIA. 2015; 56(3): 450-459.
Full papers/articles (Journal)
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia.
Awan, FT; Hillmen, P; Hellmann, A; Robak, T; Hughes, SG; Trone, D; Shannon, M; Flinn, IW; Byrd, JC;
Br J Haematol. 2014; 167(4): 466-477.
Full papers/articles (Journal)
Analysis of the safety and pharmacodynamics of human fibrinogen concentrate in animals.
Beyerle, A; Nolte, MW; Solomon, C; Herzog, E; Dickneite, G
TOXICOL APPL PHARM. 2014; 280(1): 70-77.
Full papers/articles (Journal)
Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial.
Eisterer, W; De Vries, A; Öfner, D; Rabl, H; Koplmüller, R; Greil, R; Tschmelitsch, J; Schmid, R; Kapp, K; Lukas, P; Sedlmayer, F; Höfler, G; Gnant, M; Thaler, J;
Anticancer Res. 2014; 34(11):676-673
Full papers/articles (Journal)
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).
Hutterer, M; Nowosielski, M; Haybaeck, J; Embacher, S; Stockhammer, F; Gotwald, T; Holzner, B; Capper, D; Preusser, M; Marosi, C; Oberndorfer, S; Moik, M; Buchroithner, J; Seiz, M; Tuettenberg, J; Herrlinger, U; Wick, A; Vajkoczy, P; Stockhammer, G;
Neuro Oncol. 2014; 16(1):9-102
Full papers/articles (Journal)
Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
Kwan, P; Trinka, E; Van Paesschen, W; Rektor, I; Johnson, ME; Lu, S;
Epilepsia. 2014; 55(1):38-46
Full papers/articles (Journal)
When to start aripiprazole therapy in patients with bipolar mania.
Sayyaparaju, KK; Grunze, H; Fountoulakis, KN;
Neuropsychiatr Dis Treat. 2014; 10:459-470
Intravenous sildenafil i.v. as rescue treatment for refractory pulmonary hypertension in extremely preterm infants.
Steiner, M; Salzer, U; Baumgartner, S; Waldhoer, T; Klebermass-Schrehof, K; Wald, M; Langgartner, M; Berger, A;
Klin Padiatr. 2014; 226(4):211-215
Full papers/articles (Journal)
Efficacy and safety of intravenous valproate for status epilepticus: a systematic review.
Trinka, E; Höfler, J; Zerbs, A; Brigo, F;
CNS Drugs. 2014; 28(7):623-639
Full papers/articles (Journal)
The established status epilepticus trial 2013.
Bleck, T; Cock, H; Chamberlain, J; Cloyd, J; Connor, J; Elm, J; Fountain, N; Jones, E; Lowenstein, D; Shinnar, S; Silbergleit, R; Treiman, D; Trinka, E; Kapur, J;
Epilepsia. 2013; 54 Suppl 6: 89-92.
Full papers/articles (Journal)
Development of new treatment approaches for epilepsy: Unmet needs and opportunities.
French, JA; White, HS; Klitgaard, H; Holmes, GL; Privitera, MD; Cole, AJ; Quay, E; Wiebe, S; Schmidt, D; Porter, RJ; Arzimanoglou, A; Trinka, E; Perucca, E;
Epilepsia. 2013; 54 Suppl 4: 3-12.
Full papers/articles (Journal)
Safety and tolerability of zonisamide in elderly patients with epilepsy.
Trinka, E; Giorgi, L; Patten, A; Segieth, J;
Acta Neurol Scand. 2013; 128(6):422-428
Full papers/articles (Journal)
Trinka, E; Segieth, J; Giorgi, L
J NEUROL NEUROSUR PS. 2013; 84(11):
Abstracts (Journal)
Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial.
Aschner, P; Chan, J; Owens, DR; Picard, S; Wang, E; Dain, MP; Pilorget, V; Echtay, A; Fonseca, V;
Lancet. 2012; 379(9833): 2262-2269.
Full papers/articles (Journal)
Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study.
Thaler, J; Karthaus, M; Mineur, L; Greil, R; Letocha, H; Hofheinz, R; Fernebro, E; Gamelin, E; Baños, A; Köhne, CH;
BMC Cancer. 2012; 12: 438
Full papers/articles (Journal)
Ideal characteristics of an antiepileptic drug: how do these impact treatment decisions for individual patients?
Trinka, E
ACTA NEUROL SCAND. 2012; 126(194): 10-18.
First long-term experience with the orphan drug rufinamide in children with myoclonic-astatic epilepsy (Doose syndrome).
von Stülpnagel, C; Coppola, G; Striano, P; Müller, A; Staudt, M; Kluger, G;
EUR J PAEDIATR NEURO. 2012; 16(5): 459-463.
Full papers/articles (Journal)
Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.
Fischer von Weikersthal, L; Schalhorn, A; Stauch, M; Quietzsch, D; Maubach, PA; Lambertz, H; Oruzio, D; Schlag, R; Weigang-Köhler, K; Vehling-Kaiser, U; Schulze, M; Truckenbrodt, J; Goebeler, M; Mittermüller, J; Bosse, D; Szukics, B; Grundeis, M; Zwingers, T; Giessen, C; Heinemann, V;
Eur J Cancer. 2011; 47(2): 206-214.
Full papers/articles (Journal)
Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma.
Gökbuget, N; Hartog, CM; Bassan, R; Derigs, HG; Dombret, H; Greil, R; Hernández-Rivas, JM; Huguet, F; Intermesoli, T; Jourdan, E; Junghanss, C; Leimer, L; Moreno, MJ; Reichle, A; Ribera, J; Schmid, M; Serve, H; Stelljes, M; Stuhlmann, R; Hoelzer, D;
Haematologica. 2011; 96(2): 238-244.
Full papers/articles (Journal)
Intravenous lacosamide in status epilepticus and seizure clusters.
Höfler, J; Unterberger, I; Dobesberger, J; Kuchukhidze, G; Walser, G; Trinka, E;
Epilepsia. 2011; 52(10): e148-e152.
Full papers/articles (Journal)
Intravenous lacosamide for treatment of status epilepticus.
Kellinghaus, C; Berning, S; Immisch, I; Larch, J; Rosenow, F; Rossetti, AO; Tilz, C; Trinka, E;
Acta Neurol Scand. 2011; 123(2): 137-141.
Full papers/articles (Journal)
[Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate].
Steinhoff, BJ; Trinka, E; Wendling, AS;
Nervenarzt. 2011; 82(6): 764-767.
Full papers/articles (Journal)
Oral micronized progesterone combined with vaginal progesterone gel for luteal support.
Tomic, V; Tomic, J; Klaic, DZ;
Gynecol Endocrinol. 2011; 27(12): 1010-1013.
Full papers/articles (Journal)
What is the evidence to use new intravenous AEDs in status epilepticus?
Trinka, E
EPILEPSIA. 2011; 52: 35-38.
Full papers/articles (Journal)
Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen.
Brucker, C; Hedon, B; The, HS; Höschen, K; Binder, N; Christoph, A;
Contraception. 2010; 81(6): 501-509.
Full papers/articles (Journal)
Flexible dosing of adjunctive zonisamide in the treatment of adult partial-onset seizures: a non-comparative, open-label study (ZEUS).
Dupont, S; Striano, S; Trinka, E; Springub, J; Giallonardo, AT; Smith, P; Ellis, S; Yeates, A; Baker, G;
Acta Neurol Scand. 2010; 121(3):141-148
Full papers/articles (Journal)
[Acute and long-term treatment for bipolar depression].
Grunze, H; Dargel, S;
Nervenarzt. 2010; 81(5):539-548
Full papers/articles (Journal)
New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
Lagler, FB; Gersting, SW; Zsifkovits, C; Steinbacher, A; Eichinger, A; Danecka, MK; Staudigl, M; Fingerhut, R; Glossmann, H; Muntau, AC;
Biochem Pharmacol. 2010; 80(10): 1563-1571.
Full papers/articles (Journal)
Nonresected non-small-cell lung cancer in Stages I through IIIB: accelerated, twice-daily, high-dose radiotherapy--a prospective Phase I/II trial with long-term follow-up.
Wurstbauer, K; Deutschmann, H; Kopp, P; Kranzinger, M; Merz, F; Nairz, O; Studnicka, M; Sedlmayer, F;
INT J RADIAT ONCOL. 2010; 77(5): 134-151.
Full papers/articles (Journal)
Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib.
Cannon, CP; Dansky, HM; Davidson, M; Gotto, AM; Brinton, EA; Gould, AL; Stepanavage, M; Liu, SX; Shah, S; Rubino, J; Gibbons, P; Hermanowski-Vosatka, A; Binkowitz, B; Mitchel, Y; Barter, P;
Am Heart J. 2009; 158(4):-519.e3.
Full papers/articles (Journal)
New treatment options in status epilepticus: a critical review on intravenous levetiracetam.
Trinka, E; Dobesberger, J;
Ther Adv Neurol Disord. 2009; 2(2):79-91
Full papers/articles (Journal)
A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
Bowden, C; Göğüş, A; Grunze, H; Häggström, L; Rybakowski, J; Vieta, E;
Int Clin Psychopharmacol. 2008; 23(5):254-262
Full papers/articles (Journal)
Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing: results of clinical experience in Germany.
Brucker, C; Karck, U; Merkle, E;
Eur J Contracept Reprod Health Care. 2008; 13(1): 31-38.
Full papers/articles (Journal)
Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
Jakesz, R; Greil, R; Gnant, M; Schmid, M; Kwasny, W; Kubista, E; Mlineritsch, B; Tausch, C; Stierer, M; Hofbauer, F; Renner, K; Dadak, C; Rücklinger, E; Samonigg, H;
J Natl Cancer Inst. 2007; 99(24):1845-1853
Full papers/articles (Journal)
Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.
Simunic, V; Tomic, V; Tomic, J; Nizic, D;
Fertil Steril. 2007; 87(1): 83-87.
Full papers/articles (Journal)
Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
von Stuelpnagel, C; Holthausen, H; Kluger, G;
Eur J Paediatr Neurol. 2007; 11(6): 341-345.
Full papers/articles (Journal)
Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients.
Mühlbacher, M; Konstantinidis, A; Kasper, S; Eichberger, G; Hinterhuber, H; Hofmann, P; Nimmerrichter, A; Schubert, H; Egger, C; Nickel, M; Stuppaeck, C;
Neuropsychobiology. 2006; 53(2):83-87
Full papers/articles (Journal)
First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055.
Raus, K; Brucker, C; Gorkow, C; Wuttke, W;
Menopause. 2006; 13(4): 678-691.
Full papers/articles (Journal)
Treatment of a large coronary saphenous bypass graft aneurysm by implantation of covered stents.
Zahn, R; Jessl, J; Achenbach, S; Ropers, D; Schwab, J; Daniel, W
Clin Res Cardiol. 2006; 95(6):313-315
Full papers/articles (Journal)
Zotepine loading in acute and severely manic patients: a pilot study.
Amann, B; Sterr, A; Mergl, R; Dittmann, S; Seemüller, F; Dobmeier, M; Orth, M; Schaefer, M; Grunze, H;
Bipolar Disord. 2005; 7(5):471-476
Full papers/articles (Journal)
Levetiracetam in children with refractory epilepsy: A multicenter open label study in Germany
Opp, J; Tuxhorn, I; May, T; Kluger, G; Wiemer-Kruel, A; Kurlemann, G; Gross-Selbeck, G; Rating, D; Brandl, U; Bettendorf, U; Hartel, C; Korn-Merker, E
SEIZURE-EUR J EPILEP. 2005; 14(7): 476-484.
Full papers/articles (Journal)
The safety and tolerability of atypical antipsychotics in bipolar disorder.
Seemüller, F; Forsthoff, A; Dittmann, S; Born, C; Bernhard, B; Severus, WE; Grunze, H;
Expert Opin Drug Saf. 2005; 4(5):849-868
Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design.
Grunze, H; Langosch, J; Born, C; Schaub, G; Walden, J;
J Clin Psychiatry. 2003; 64(7):781-784
Full papers/articles (Journal)
Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol.
Grunze, H; Marcuse, A; Schärer, LO; Born, C; Walden, J;
Neuropsychobiology. 2002; 46 Suppl 1:31-35
Full papers/articles (Journal)
Intralymphatic interleukin-2 in combination with zidovudine for the therapy of patients with AIDS.
Harrer, T; Schwab, J; Struff, WG; Schmitt, M; Ficker, JH; Rodl, W; Parsch, H; Kalden, JR; Gramatzki, M
Infection. 1998; 26(6):368-374
Full papers/articles (Journal)
Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial.
Krajnik, G; Wein, W; Greil, R; Marhold, F; Mohn-Staudner, A; Kummer, F; Malayeri, R; Zöchbauer-Müller, S; Huber, H; Pirker, R;
Eur J Cancer. 1998; 34(12): 1977-1980.
Full papers/articles (Journal)
Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.
Thaler, J; Hilbe, W; Apfelbeck, U; Linkesch, W; Sill, H; Seewann, H; Pont, J; Bernhart, M; Stöger, M; Niessner, H; Abbrederis, K; Geissler, D; Hausmaninger, H; Lin, W; Ludwig, H; Lang, A; Duba, C; Fluckinger, T; Greil, R; Grünewald, K; Konwalinka, G; Niederwieser, D; Fridrik, M;
Leuk Res. 1997; 21(1):75-80
Full papers/articles (Journal)
A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
Hebenstreit, GF; Laux, G; Schubert, H; Beckmann, H; Amman, J; Bunse, J; Eikmeier, G; Geretsegger, C; Kanitz, RD; Kanzow, WT;
Pharmacopsychiatry. 1991; 24(5): 153-158.
Full papers/articles (Journal)
Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria.
Hebenstreit, GF; Loidl, M; Baumhackl, U; Gallhofer, B; Geretsegger, C; Radmayr, E; Saletu, M; Schöny, W; Stabl, M;
J Neural Transm Suppl. 1990; 32:177-184
Full papers/articles (Journal)